Below is Validea's guru fundamental report for TEMPUS AI INC (TEM). Of the 22 guru strategies we follow, TEM rates highest using our P/B Growth Investor model based on the published strategy of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other AI stocks. In a recent discussion at CNBC’s ‘Squawk on the Street’, NYU professor ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other stocks. Wall Street extended a lackluster performance on Tuesday, with two of its major ...

Popular investor Cathie Wood and her Ark Invest funds took advantage of a buying opportunity on Tuesday by purchasing over 400,000 shares of Tempus AI (TEM) as the stock plummeted 15%. This move ...

Researchers have developed a new optical computing material from photon avalanching nanoparticles. A research team co-led by Lawrence Berkeley National Laboratory (Berkeley Lab), Columbia ...

Deep Nanometry can detect rare nanoparticles with high speed and precision, using AI to filter out background noise. This breakthrough could transform disease diagnostics, vaccine development, and ...

Non-Commercial (NC): Only non-commercial uses of the work are permitted. This work reports for the first time the fabrication of metallic nanoparticles from platinum material (Pt-NPs) implying pulsed ...

In studies using mice and human brain tissue, these nanoparticles successfully delivered therapeutic mRNA, opening doors for potential treatments for neurological diseases like Alzheimer’s, ALS, and ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other stocks. The stock market may have registered losses on Friday, but remained firmer on a ...

Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs. TEM, which is up 161% in 2025 so far, has been one ...